Company Legal Name
Latest Valuation
Founded Year
Headquarter
Eikon Therapeutics operates a drug discovery platform that combines live-cell protein tracking technology with advanced data science to develop treatments for serious diseases. Founded in 2019 and headquartered in Hayward, California, the company differentiates itself through its proprietary approach to observing protein behavior in living cells, providing unprecedented insights into disease mechanisms. This innovative methodology enables more precise identification of therapeutic targets and drug candidates compared to traditional discovery methods. The company focuses on leveraging its unique technological capabilities to advance a pipeline of potential treatments addressing significant unmet medical needs in various therapeutic areas.
Available in most regions; subject to local regulations.
Open to non-accredited investors with KYC/AML compliance. U.S. investors must meet SEC requirements.
$10 per token, enabling fractionalized access to Pre-IPO shares.
Mandatory identity (KYC) and proof of funds checks.
Variable, applied to investment amounts.
Charged on realized profits.
Tokens may be locked for 6–12 months; resale depends on secondary market liquidity.
Prices reflect past funding rounds, not guaranteed future value.
Biotech depends on regulatory approvals; fintech faces evolving digital asset rules.
Blockchain or custodian issues could delay transfers or verification.
Changing laws may affect tradability or taxation.
How can I buy Eikon Therapeutics pre-IPO shares through Jarsy?
You can create an account, complete KYC verification, and start investing from just $10. Shares are fractionalized, so you can access pre-IPO opportunities without high entry barriers.
What is the current stock price and valuation of Eikon Therapeutics ?
The latest valuation of Eikon Therapeutics is , The live stock price chart shows historical price movements and company valuation trends. Investors can track performance before the IPO.
What is the minimum investment amount required to invest in Eikon Therapeutics ?
The minimum investment is $10, enabling fractionalized access to Eikon Therapeutics pre-IPO shares.
What fees will I pay when investing in Eikon Therapeutics pre-IPO shares?
Fees include platform fees and carried interest on realized profits.
What risks are involved in Eikon Therapeutics pre-IPO stock investments?
Risks include liquidity lock-ups, valuation uncertainty, industry-specific risks, regulatory changes, and potential custody or tokenization issues.
How does Jarsy ensure transparency of reserves and assets?
Each Jarsy issued Token is backed 1:1 by the economic rights of a corresponding share held by Jarsy’s Delaware LLC ( an LLC created for custody purposes). When a liquidation event happens, Jarsy would liquidate the shares and return the equivalent dollar value to token holders based on their economic interest. This structure ensures full transparency and direct backing of every token. All the supply and transactions information of the token can be verified independently through blockchain.
Can I sell my Eikon Therapeutics pre-IPO shares backed token before the IPO?
You may redeem your tokens through the Jarsy platform; however, settlement is not guaranteed and is subject to available liquidity and market demand.